Mary E Temple
Impact in
- Biotechnology top 5%
- Listeria monocytogenes in Food Safety
- Toxicology top 5%
- Pharmacovigilance and Adverse Drug Reactions
Papers in
-
- Tuberculosis Research and Epidemiology 2
- Viral gastroenteritis research and epidemiology 1
-
- Prenatal Substance Exposure Effects 2
- Co-authors
- Aileen Bown Luzier (1 shared paper)David J. Kazierad (1 shared paper)Katalin I. Koranyi (5 shared papers)Renee F. Robinson (1 shared paper)Jason T. Connor (1 shared paper)Susana Arrigain (1 shared paper)Janet R. Reid (1 shared paper)A. Marc Harrison (1 shared paper)
- Journals
- Annals of Pharmacotherapy (7 papers)American Journal of Health-System Pharmacy (4 papers)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (3 papers)Journal of the American Geriatrics Society (1 paper)Drug Safety (1 paper)
- Partner nations
- United StatesIndia
In The Last Decade
Mary E Temple
22 papers receiving 499 citations
Peers
Comparison fields: 5 of 72
- Biotechnology 111
- Toxicology 47
- Infectious Diseases 73
- Microbiology 24
- Rheumatology 41
Countries citing papers authored by Mary E Temple
This map shows the geographic impact of Mary E Temple's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary E Temple with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary E Temple more than expected).
Fields of papers citing papers by Mary E Temple
This network shows the impact of papers produced by Mary E Temple. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary E Temple. The network helps show where Mary E Temple may publish in the future.
Co-authors
The 13 scholars most cited alongside Mary E Temple, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 166 | |
| 2 | 2000 | 70 | |
| 3 | 2004 | 66 | |
| 4 | 2005 | 53 | |
| 5 | 1999 | 38 | |
| 6 | 2000 | 22 | |
| 7 | 2001 | 19 | |
| 8 | 2000 | 16 | |
| 9 | 2001 | 16 | |
| 10 | 2003 | 14 | |
| 11 | 2014 | 13 | |
| 12 | 2017 | 12 | |
| 13 | 1999 | 11 | |
| 14 | 2001 | 9 | |
| 15 | 2000 | 8 | |
| 16 | 2013 | 4 | |
| 17 | 1999 | 3 | |
| 18 | 1999 | 2 | |
| 19 | 2000 | 2 | |
| 20 | 2001 | 2 |
About Mary E Temple
Mary E Temple is a scholar working on Infectious Diseases, Pediatrics, Perinatology and Child Health, Applied Microbiology and Biotechnology, Toxicology and Otorhinolaryngology, having authored 22 papers that have together received 548 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (2 papers), Prenatal Substance Exposure Effects (2 papers), Blood Pressure and Hypertension Studies (1 paper), Hepatitis C virus research (1 paper), Viral gastroenteritis research and epidemiology (1 paper), Infectious Diseases and Mycology (1 paper), Medical Education and Admissions (1 paper) and Ocular Infections and Treatments (1 paper). The work is most often cited by research in Biotechnology (111 citations), Toxicology (47 citations), Infectious Diseases (73 citations), Microbiology (24 citations) and Rheumatology (41 citations). Mary E Temple has collaborated with scholars based in United States and India. Frequent co-authors include Aileen Bown Luzier, David J. Kazierad, Katalin I. Koranyi, Renee F. Robinson, Jason T. Connor, Susana Arrigain, Janet R. Reid, A. Marc Harrison, Stuart C. Morrison and Michael T. Brady. Their work appears in journals such as Annals of Pharmacotherapy, American Journal of Health-System Pharmacy, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, Journal of the American Geriatrics Society and Drug Safety.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.